SCHEMBL25737802

SCHEMBL25737802

CCc1ccc(C(=O)NCC(F)(F)F)nc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 1/20 0.50
LMNA P02545 2/20 0.47
POLB P06746 1/20 0.47
MAPT P10636 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
SCN9A Q15858 2/20 0.41
SCN10A Q9Y5Y9 2/20 0.41
PARP1 P09874 1/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
PKM P14618 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
NFKB1 P19838 1/20 0.40
THPO P40225 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9908372 0.83 PARP1 (0.53) LMNAMAPTSMN1; SMN2NPC1RAB9A
SCHEMBL840084 0.80 MAPK1 (0.60) LOXL2LMNAPOLBSMN1; SMN2SCN9A
SCHEMBL15747506 0.79 ALDH1A1 (0.50) LOXL2SCN9ASCN10AKDM4EALDH1A1
SCHEMBL12924077 0.78 PDE10A (0.55) LOXL2POLBRAB9ASCN9ASCN10A
SCHEMBL12561176 0.78 PLK1 (0.55) LMNAMAPTSMN1; SMN2NPC1RAB9A
SCHEMBL24956517 0.77 LOXL2 (0.48) LOXL2SCN9ASCN10AGABRA1
SCHEMBL840724 0.77 LOXL2 (0.50) LOXL2SMN1; SMN2NPC1RAB9ASCN9A
SCHEMBL4475119 0.76 LMNA (0.64) LMNAPOLBSMN1; SMN2NPC1RAB9A
SCHEMBL27308715 0.76 MAPT (0.49) LMNAMAPTSMN1; SMN2NPC1RAB9A
SCHEMBL14524662 0.76 L3MBTL1 (0.44) MAPTSMN1; SMN2KDM4ETDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023109521-A1 PARP INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF 凯复(苏州)生物医药有限公司 2023-06-22 WO disclosed